Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-9.886M
Cash
20.0M
Avg Qtr Burn
-6.798M
Short % of Float
0.18%
Insider Ownership
1.29%
Institutional Own.
7.38%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Macimorelin (Macrilen®; GHRYVELIN™) Details Pediatric growth hormone deficiency | Phase 3 Data readout |